In this episode of MD Newsline, Dr. Michael Albert, obesity medicine specialist, internist, and Co-Founder of Accomplish Health, joins Dr. Spencer Nadolsky, board-certified obesity physician, family physician, lipidologist, and Founder of Vineyard, for an expert roundtable on the rapidly evolving landscape of Medicare coverage for obesity treatment. They discuss how GLP-1 receptor agonists, evolving CMS policies, and the proposed Medicare bridge model are changing obesity care for older adults while highlighting the importance of personalized medicine, long-term chronic disease management, clinical documentation, and multidisciplinary care. The conversation also explores barriers to medication access, prior authorization challenges, care infrastructure, patient education, and how success in obesity treatment should be measured beyond the number on the scale. Episode Highlights Medicare Coverage and Access to GLP-1 Medications Drs. Albert and Nadolsky explain why the greatest barrier to obesity treatment is often not identifying appropriate patients—but helping them obtain and maintain access to therapy. They discuss Medicare Part D coverage, prior authorization requirements, step therapy, and how insurance policies frequently determine clinical decision-making. Understanding the Medicare GLP-1 Bridge Program The discussion examines proposed Medicare eligibility criteria for GLP-1 therapies, including BMI thresholds, cardiovascular disease, chronic kidney disease, hypertension, and other qualifying conditions. The physicians explain how these criteria differ from traditional FDA labeling and what clinicians need to document for approval. Building Clinical Infrastructure for Success Effective obesity care requires more than prescribing medication. Dr. Albert shares how custom EHR workflows, automated documentation, digital intake tools, and streamlined prior authorization systems help practices deliver high-quality obesity care at scale while reducing administrative burden. Personalizing GLP-1 Therapy for Older Adults Older adults require individualized treatment strategies to minimize frailty, sarcopenia, dehydration, and gastrointestinal side effects. The physicians discuss dose titration, oral versus injectable formulations, nutritional monitoring, resistance exercise, and shared decision-making to safely optimize treatment. Setting Expectations for Long-Term Treatment Obesity is a chronic disease that often requires lifelong management. Drs. Albert and Nadolsky emphasize informed consent, discussing medication costs, potential loss of coverage, weight regain after discontinuation, and the importance of preparing patients for long-term therapy. Documentation That Improves Access The panel reviews best practices for documenting obesity severity, BMI, ICD-10 coding, and obesity-related comorbidities such as diabetes, hypertension, obstructive sleep apnea, cardiovascular disease, and chronic kidney disease. Accurate documentation helps improve approval rates while supporting evidence-based care. Multidisciplinary Care and Care Coordination Managing obesity effectively requires collaboration among primary care physicians, obesity specialists, dietitians, cardiologists, endocrinologists, nephrologists, and bariatric surgeons. The physicians discuss referral pathways, closed-loop communication, digital health systems, and coordinated care models that improve patient outcomes. Measuring Success Beyond Weight Loss While weight reduction remains important, the physicians argue that true success should be measured by improvements in metabolic health, cardiovascular risk, mobility, functional independence, quality of life, medication reduction, and the ability to perform everyday activities—not simply achieving a target percentage of weight loss. Key Takeaway Drs. Albert and Nadolsky emphasize that obesity is a chronic disease, not simply a lifestyle issue, and effective treatment requires long-term access to GLP-1 medications, personalized care, thoughtful clinical infrastructure, multidisciplinary support, and patient-centered decision-making. As Medicare expands access to obesity therapies, success will depend not only on prescribing innovative medications but also on creating healthcare systems that deliver equitable, sustainable, and comprehensive obesity care while measuring outcomes by overall health, function, and quality of life rather than weight loss alone. Resources MD Newsline Website: https://mdnewsline.com/ Newsletter: https://mdnewsline.com/subscribe/ Featured Guests Dr. Michael Albert Co-Founder & Chief Medical Officer, Accomplish Health Obesity Medicine Specialist & Internist https://michaelalbertmd.com/ Dr. Spencer Nadolsky Founder, Vineyard Board-Certified Obesity Medicine Physician, Family Physician & Lipidologist https://drspencer.com/
